BRAF-MEK inhibitors as steroid-sparing bridge prior to checkpoint blockade therapy in symptomatic intracranial melanoma

Lignende værker

• The Landscape of Novel Therapeutics and Challenges in Glioblastoma Multiforme: Contemporary State and Future Directions
  af: Khaddour, Karam, et al.
  Udgivet: (2020)
• Successful administration of sequential TVEC and pembrolizumab followed by Temozolomide in immunotherapy refractory intracranial metastatic melanoma with acquired B2M mutation
  af: Khaddour, Karam, et al.
  Udgivet: (2020)
• BRAF/MEK double blockade in refractory anaplastic pleomorphic xanthoastrocytoma
  af: Migliorini, Denis, et al.
  Udgivet: (2017)
• Therapeutic potential of combined BRAF/MEK blockade in BRAF-wild type preclinical tumor models
  af: Del Curatolo, Anais, et al.
  Udgivet: (2018)
• Immunomodulatory Effects of BRAF, MEK, and CDK4/6 Inhibitors: Implications for Combining Targeted Therapy and Immune Checkpoint Blockade for the Treatment of Melanoma
  af: Lelliott, Emily J., et al.
  Udgivet: (2021)